Vallé-Jones J C
J Int Med Res. 1977;5(1):65-7. doi: 10.1177/030006057700500111.
An open clinical trial of Locabiotal, in which the antibiotic, fusafungine, is presented in a micronized aerosol was performed in general practice. One hundred and ten patients suffering from upper respiratory infections without associated hyperpyrexia or toxic symptoms were treated for 7 days. There was a marked improvement in the symptoms rated during the first 48 hours. After the full course of treatment 37 patients regarded its effect as excellent and 48 as good.
在普通医疗实践中进行了一项关于Locabiotal的开放性临床试验，该产品将抗生素夫沙芬净制成微粉化气雾剂。110例无相关高热或中毒症状的上呼吸道感染患者接受了7天的治疗。在最初48小时内，症状有明显改善。在整个疗程结束后，37例患者认为其效果极佳，48例认为效果良好。
